{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:06:21Z","timestamp":1791925581653,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nbd.2020.104795","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:43:57Z","timestamp":1580989437000},"page":"104795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"special_numbering":"C","title":["Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease"],"prefix":"10.1016","volume":"138","author":[{"given":"D. Allan","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104795_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","article-title":"Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide, and proteomics","volume":"39","author":"Aluise","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nbd.2007.11.004","article-title":"Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease","volume":"29","author":"Bader-Lange","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1373\/clinchem.2004.045955","article-title":"Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele","volume":"51","author":"Bernardini","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.nbd.2020.104795_bb0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0024-3205(95)00055-B","article-title":"Bioenergetic and oxidative stress in neurodegenerative diseases","volume":"56","author":"Bowling","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2020.104795_bb0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0891-5849(02)00803-1","article-title":"Apolipoprotein E isoform mediated regulation of nitric oxide release","volume":"32","author":"Brown","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2014.06.006","article-title":"The 2013 SFRBM discovery award: selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive mpairment","volume":"74","author":"Butterfield","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jnc.14589","article-title":"Redox proteomics and amyloid \u03b2-peptide: insights into Alzheimer disease","volume":"151","author":"Butterfield","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, gluocose dysmetabolism, and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104795_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1566-3124(08)60057-7","article-title":"Protein oxidation processes in aging brain","volume":"2","author":"Butterfield","year":"1997","journal-title":"Adv. Cell Aging Gerontol."},{"key":"10.1016\/j.nbd.2020.104795_bb0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer\u2019s disease brain: central role of amyloid \u03b2-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2005.11.002","article-title":"Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease","volume":"22","author":"Butterfield","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2005.12.017","article-title":"Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment","volume":"397","author":"Butterfield","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2020.104795_bb0065","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainres.2007.02.084","article-title":"Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer\u2019s disease","volume":"1148","author":"Butterfield","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10715762.2010.520014","article-title":"Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer\u2019s disease","volume":"45","author":"Butterfield","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0080","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1089\/ars.2011.4109","article-title":"Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications","volume":"17","author":"Butterfield","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2020.104795_bb0085","doi-asserted-by":"crossref","first-page":"32583","DOI":"10.1038\/srep32583","article-title":"Integration of transcriptomic and genomic data suggests candidate mechanisms for ApoE4-mediated pathogenic action in Alzheimer\u2019s disease","volume":"6","author":"Caberlotto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104795_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/JAD-161299","article-title":"Apolipoprotein E4, gender, body mass index, inflammation, insulin resistance, and air pollution interactions: recipe for Alzheimer\u2019s disease development in Mexico City young females","volume":"58","author":"Calderon-Garciduenas","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/bpa.12402","volume":"26","author":"Cardoso","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104795_bb0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1582-4934.2007.00130.x","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: molecular mechanisms and therapeutic opportunities","volume":"11","author":"Cedazo-Minguez","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1582-4934.2001.tb00159.x","article-title":"Apolipoprotein E: a major piece in the Alzheimer disease puzzle","volume":"5","author":"Cedazo-Minguez","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2014.08.006","article-title":"An investigation of the molecular mechaisms engaged before and after the development of Alzheimer disease neuropathology in down syndrome: a proteomics approach","volume":"76","author":"Cenini","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0115","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","article-title":"Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity","volume":"102","author":"Chang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104795_bb0120","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.freeradbiomed.2004.02.002","article-title":"Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer\u2019s disease","volume":"36","author":"Choi","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104795_bb0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00016-7","article-title":"APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress","volume":"23","author":"Colton","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-132228","article-title":"Increased susceptibility to amyloid-\u03b2-induced neurotoxicity in mice lacking the low-density lipoprotein receptor","volume":"41","author":"De Oliveira","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.12.004","article-title":"Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients","volume":"64","author":"Di Domenico","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/ars.2016.6759","article-title":"The triangle of death in Alzheimer disease brain: the aberrant cross talk among energy metabolism, mTOR signaling and protein homeostasis revealed by redox proteomics","volume":"26","author":"Di Domenico","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2020.104795_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","article-title":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders","volume":"111","author":"Di Domenico","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.08.009","article-title":"mTOR in down syndrome: role in A\u03b2 and tau neuropathology and transition to Alzheimer disease-like dementia","volume":"114","author":"Di Domenico","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Di Domenico","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2020.104795_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","article-title":"APOE genotype and stress response \u2013 a mini review","volume":"15","author":"Dose","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0079-6123(08)63214-8","article-title":"Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture","volume":"118","author":"Estevez","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0180","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/acs.chemrev.7b00568","article-title":"Biochemistry of peroxynitrite and protein tyrosine nitration","volume":"118","author":"Ferrer-Sueta","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.nbd.2020.104795_bb0185","doi-asserted-by":"crossref","first-page":"746329","DOI":"10.1155\/2015\/746329","article-title":"Association of the C47T polymorphism in SOD2 with amnestic mild cognitive impairment and Alzheimer\u2019s disease in carriers of the ApoE\u03b54 allele","volume":"2015","author":"Gamarra","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.nbd.2020.104795_bb0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","article-title":"The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer\u2019s disease","volume":"30","author":"Glodzik-Sobanska","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0195","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1074\/jbc.271.18.10602","article-title":"The interaction between apolipoprotein E and Alzheimer\u2019s amyloid beta-peptide is dependent on beta-peptide conformation","volume":"271","author":"Golabek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104795_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0205","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2015"},{"key":"10.1016\/j.nbd.2020.104795_bb0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1381612820666141020164222","article-title":"The APOE genotype: modification of therapeutic responses in Alzheimer\u2019s disease","volume":"21","author":"Hanson","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2020.104795_bb0215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2017.09.013","article-title":"Down syndrome, beta-amyloid and neuroimaging","volume":"114","author":"Head","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0220","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","article-title":"Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation","volume":"65","author":"Hensley","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/35036221","article-title":"Apolipoprotein E receptors: linking brain development and Alzheimer\u2019s disease","volume":"1","author":"Herz","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104795_bb0230","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104795_bb0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2019.05.006","article-title":"Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE \u03b53, but not APOE \u03b54, targeted replacement mice","volume":"81","author":"Jiang","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0240","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1046\/j.1471-4159.2000.0741579.x","article-title":"Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice","volume":"74","author":"Keller","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0245","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104795_bb0250","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/bi002312k","article-title":"Vulnerability of synaptosomes from apoE knock-out mice to structureal and oxidative modifications induced by Abeta(1-40): implications for Alzheimer\u2019s disease","volume":"40","author":"Lauderback","year":"2001","journal-title":"Biochem."},{"key":"10.1016\/j.nbd.2020.104795_bb9005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: Role of Ab1-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-8993(01)03228-0","article-title":"Apolipoprotein E modulates Alzheimer\u2019s Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner","volume":"924","author":"Lauderback","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0260","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1038\/s41598-017-08604-8","article-title":"Targeting apolipoprotein E\/amyloid \u03b2 binding by peptoid CPO_A\u03b217-21 amerliorates Alzheimer\u2019s disease related pathology and cognitive decline","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104795_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/biom2010143","article-title":"Mortalin, apoptosis, and neurodegeneration","volume":"2","author":"Londono","year":"2012","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2020.104795_bb0270","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104795_bb0275","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104795_bb0280","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1523\/JNEUROSCI.15-09-06239.1995","article-title":"Amyloid beta-peptide imparies ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death","volume":"15","author":"Mark","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104795_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2010-1220","article-title":"Neuropathological alterations in mild cognitive impairment: a review","volume":"19","author":"Markesbery","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0290","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3233\/JAD-171145","article-title":"Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies \u2013 gains from AIBL and DIAN cohort studies","volume":"62","author":"Martins","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2009.07.003","article-title":"Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders","volume":"44","author":"Mattson","year":"2009","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2020.104795_bb0300","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-170732","article-title":"A Long journey into aging, brain aging, and Alzheimer\u2019s disease following the oxidative stress tracks","volume":"62","author":"Mecocci","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005072-199602000-00009","article-title":"Crosslinking of apolipoprotein E by products of lipid peroxidation","volume":"55","author":"Montine","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/ars.2005.7.269","article-title":"F2-isoprostanes in Alzheimer and other neurodegenerative diseases","volume":"7","author":"Montine","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2020.104795_bb0315","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3233\/JAD-150993","article-title":"The genetic variability of UCP4 affects the individual susceptibility to late-onset Alzheimer\u2019s disease and modifies the disease\u2019s risk in APOE-\u03b54 carriers","volume":"51","author":"Montsanto","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0320","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11064-018-2629-1","article-title":"Understanding the role of ApoE fragments in Alzheimer\u2019s disease","volume":"44","author":"Munoz","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2017.01.033","article-title":"Daily rhythms of cognition-related factors are modified in an experimental model of Alzheimer\u2019s disease","volume":"1660","author":"Navigatore-Fonzo","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"18","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0335","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb9000","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neurobiolaging.2006.09.012","article-title":"Proteomic identificaiton of brain proteins in the canine modle of human aging followiing a long-term treatment with antioxidants and program of behavioral enrichment: Relevance to Alzheimer's disease","volume":"29","author":"Opii","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0340","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.neurobiolaging.2006.08.011","article-title":"Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice","volume":"28","author":"Osorio","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0345","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","article-title":"Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer's disease: implications for A\u03b2 accumulation in AD brain","volume":"49","author":"Owen","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0350","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1471-4159.2000.0741426.x","article-title":"A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal","volume":"74","author":"Pedersen","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0355","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-150738","article-title":"Apolipoprotein E4 elicits lysosomal cathepsin D release, decreased thioredoxin-1 levels, and apoptosis","volume":"56","author":"Persson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0360","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2008.102","article-title":"Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer disease: associated study and relationship with apolipoprotein E epsilon4 allele","volume":"46","author":"Pinhel","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0365","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0891-5849(99)00102-1","article-title":"Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer\u2019s disease is related to apolipoprotein E genotype","volume":"27","author":"Ramassamy","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/nbdi.1999.0273","article-title":"Oxidative insults are associated with apolipoprotein E geneotype in Alzheimer\u2019s disease brain","volume":"7","author":"Ramassamy","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0169-328X(00)00268-0","article-title":"Impact of apoE deficiency on oxidative insults and antioxidants in the brain","volume":"86","author":"Ramassamy","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer disease","volume":"96","author":"Reddy","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0385","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104795_bb0390","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/bbrc.1995.1389","article-title":"Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease","volume":"208","author":"Richey","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2020.104795_bb0395","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnen\/59.9.751","article-title":"Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses","volume":"59","author":"Saunders","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.02.030","article-title":"Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer\u2019s disease pathology","volume":"42","author":"Scheff","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104795_bb0405","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma b-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104795_bb0410","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(02)01001-8","article-title":"Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue","volume":"33","author":"Shea","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0415","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"539","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104795_bb0420","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","author":"Shi","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0425","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.24628","article-title":"APOE2 eases cognitive decline during aging: clinical and preclinical evaluations","volume":"79","author":"Shinohara","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02815203","article-title":"Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles","volume":"28","author":"Smith","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.nbd.2020.104795_bb0435","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104795_bb0440","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.1997.69031161.x","article-title":"The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortial synaptosomal membrane proteins","volume":"69","author":"Subramaniam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104795_bb0445","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","article-title":"Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain","volume":"62","author":"Sultana","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2020.104795_bb0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JAD-2005-7206","article-title":"N-acetyl cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency","volume":"7","author":"Tchantchou","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0455","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","article-title":"Apolipoprotein E \u2013 a multifunctional protein with implications in various pathologies as a result of its structural features","volume":"15","author":"Tudorache","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.nbd.2020.104795_bb0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","article-title":"The role of type 2 diabetes in neurodegeneration","volume":"84","author":"Verdile","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104795_bb0465","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","article-title":"Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis","volume":"40","author":"Winkler","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2020.104795_bb0470","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.104795_bb0475","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1471-4159.2004.02532.x","article-title":"Aging, gender and APOE isotype modulate metabolism of Alzheimer\u2019s Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits","volume":"90","author":"Yao","year":"2004","journal-title":"J. Neurochem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612030070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612030070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:22Z","timestamp":1760851102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612030070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":97,"alternative-id":["S096999612030070X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104795","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104795"}}